MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-24-0025617
Synflix Pharmaceutical Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹63.52 Lakh
▲ 139% YoY
Net profit · FY 2025
₹2.33 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹5.38 Lakh
EBITDA margin 8.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹45 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Synflix Pharmaceutical Private Limited
Data last updated:
Synflix Pharmaceutical Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 15 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC120841. Its GSTIN is 33AAZCS8399G1ZC (Tamil Nadu).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹45 Lakh. It is led by directors Kannan Sudha and Arunachalam Lakshmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 99 SIDCO Industrial Estate Vichoor, Chennai, Tamil Nadu, India – 600103.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.52 Lakh, a growth of 139% compared to the previous year. For the same year it recorded a net profit of ₹2.33 Lakh (net margin 3.7%) and EBITDA of ₹5.38 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 24% over five years.
The company is associated with 1 brand: Synflix Pharma.
Synflix Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0025617). For more details, the company can be reached via its website synflixpharma.com.
Company details
CIN U74999TN2018PTC120841
Registration Number 120841
Incorporation Date 15 February 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-24-0025617
Recognitions & Rankings of Synflix Pharmaceutical
Contact details
Synflix Pharmaceutical Private Limited's registered office is in Chennai, Tamil Nadu. Its website is synflixpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 99 SIDCO Industrial Estate Vichoor, Chennai, Tamil Nadu, India – 600103
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Synflix Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Synflix Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Synflix Pharmaceutical operates one associated brand: Synflix Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Synflix Pharma is a CDMO specializing in the manufacturing of API intermediates for the biopharma sector. | synflixpharma.com |
Business activity
The main business activity of Synflix Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synflix Pharmaceutical Private Limited, buy the company report.
Financials of Synflix Pharmaceutical Private Limited
FY 2025 filings availableSynflix Pharmaceutical Private Limited reported revenue of ₹63.52 Lakh (up 139% YoY) for FY 2025.
Revenue · FY 2025
₹63.52 Lakh ▲ 139%
Net profit · FY 2025
₹2.33 Lakh margin 3.7%
EBITDA · FY 2025
₹5.38 Lakh margin 8.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 139%
3 years · compounded
▲ 28%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 110%
3 years · compounded
▲ 31%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 139% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synflix Pharmaceutical Private Limited, buy the company report.
Board of directors of Synflix Pharmaceutical Private Limited
Synflix Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannan Sudha | Director | 15 Feb 2018 | 8 Years 8 Months | Current |
| Arunachalam Lakshmi | Director | 15 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Synflix Pharmaceutical Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ergam Life Sciences Private Limited | ₹67.84 Lakh (FY 2024) | -41.0% | Hyderabad, Telangana, India | |||
| Sgpharma Global Private Limited | ₹64.31 Lakh (FY 2025) | 4077.0% | Mumbai, Maharashtra, India | |||
| Synflix Pharmaceutical Private Limitedthis company | ₹63.52 Lakh (FY 2025) | ₹2.33 Lakh | 3.7% | 139.0% | Chennai, Tamil Nadu, India | |
| Edhaa Innovations Private Limited | ₹61.97 Lakh (FY 2025) | 77.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Synflix Pharmaceutical Private Limited, buy the company report.
Auditor
Synflix Pharmaceutical Private Limited is audited by RAGHAVI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAGHAVI & CO | FY 2022 | 024251S |
Shareholding
The shareholding of Synflix Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synflix Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Synflix Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synflix Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Synflix Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAZCS8399G1ZC | Tamil Nadu | Active | 27 Mar 2018 |
To see the full GST registrations and return filing status of Synflix Pharmaceutical Private Limited, buy the company report.
Recent activity
Synflix Pharmaceutical Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Ramakrishnan Chockalingam ceased to be Director on 30 Jun 2020.
AGM
Synflix Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Synflix Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Ramakrishnan Chockalingam ceased to be Director.
Ceased
Subramanian Venkataraman ceased to be Director.
Ceased
Muthulakshmi Ramakrishnan ceased to be Director.
Appointed
Arunachalam Lakshmi was appointed as Director.
Appointed
Kannan Sudha was appointed as Director.
Incorporation
15 Feb 2018
Synflix Pharmaceutical Private Limited was registered on 15 Feb 2018 with Roc Chennai & aged 8 years 8 months as per MCA records.
Frequently asked questions
Synflix Pharmaceutical is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 15 February 2018 (8+ years old) and is registered under CIN U74999TN2018PTC120841.
Synflix Pharmaceutical has 2 current directors:
- Kannan Sudha - Director
- Arunachalam Lakshmi - Director
The latest financial statements of Synflix Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Synflix Pharmaceutical is 33AAZCS8399G1ZC, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Synflix Pharmaceutical is U74999TN2018PTC120841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synflix Pharmaceutical was incorporated on 15 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Synflix Pharmaceutical by revenue are Ergam Life Sciences Private Limited, Sgpharma Global Private Limited, Edhaa Innovations Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramakrishnan Chockalingam ceased to be Director on 30 Jun 2020. Subramanian Venkataraman ceased to be Director on 30 Jun 2020. Muthulakshmi Ramakrishnan ceased to be Director on 26 Feb 2020. Synflix Pharmaceutical has 5 board changes on record in total.
Yes, Synflix Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-24-0025617).
Synflix Pharmaceutical can be reached through the website synflixpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Synflix Pharmaceutical is at Plot No. 99 SIDCO Industrial Estate Vichoor, Chennai, Tamil Nadu, India – 600103.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages